医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
35期
87-88
,共2页
通心络胶囊%冠心病心绞痛%疗效
通心絡膠囊%冠心病心絞痛%療效
통심락효낭%관심병심교통%료효
Tongxinluo capsule%angina pectoris%Efficacy
目的：探讨研究通心络胶囊治疗冠心病心绞痛的疗效及对其安全性进行分析评价。方法将我院自2013年8月~2014年8月期间收治的112例冠心病心绞痛患者，随机分成实验组和对照组，治疗一个疗程后（4周），对比两组患者的临床效果，并作出评价。结果实验组患者心电图总有效率为89.2%(50/56)明显高于对照组75.0%(42/56)(P＜0.05)；心绞痛总有效率为92.9%(52/56)明显高于对照组73.2%(41/56)(P＜0.05)；且患者没有不良反应发生。结论通心络胶囊治疗冠心病心绞痛疗效好，副作用小，安全性高，应广泛推广应用于临床。
目的：探討研究通心絡膠囊治療冠心病心絞痛的療效及對其安全性進行分析評價。方法將我院自2013年8月~2014年8月期間收治的112例冠心病心絞痛患者，隨機分成實驗組和對照組，治療一箇療程後（4週），對比兩組患者的臨床效果，併作齣評價。結果實驗組患者心電圖總有效率為89.2%(50/56)明顯高于對照組75.0%(42/56)(P＜0.05)；心絞痛總有效率為92.9%(52/56)明顯高于對照組73.2%(41/56)(P＜0.05)；且患者沒有不良反應髮生。結論通心絡膠囊治療冠心病心絞痛療效好，副作用小，安全性高，應廣汎推廣應用于臨床。
목적：탐토연구통심락효낭치료관심병심교통적료효급대기안전성진행분석평개。방법장아원자2013년8월~2014년8월기간수치적112례관심병심교통환자，수궤분성실험조화대조조，치료일개료정후（4주），대비량조환자적림상효과，병작출평개。결과실험조환자심전도총유효솔위89.2%(50/56)명현고우대조조75.0%(42/56)(P＜0.05)；심교통총유효솔위92.9%(52/56)명현고우대조조73.2%(41/56)(P＜0.05)；차환자몰유불량반응발생。결론통심락효낭치료관심병심교통료효호，부작용소，안전성고，응엄범추엄응용우림상。
Objective To investigate the effect of Tongxinluo capsule in treating angina pectoris and to analyze and evaluate its safety. Methods in our hospital from August 2013 - admitted in August 2014 during the 112 cases of angina pectoris were randomly divided into experimental and control groups, after a course of treatment (four weeks), the clinical results compared two groups of patients, and evaluated. ECG results in patients in the experimental group, the total effective rate was 89.2% (50/56) was significantly higher than 75.0% (42/56) (P <0.05.); Angina total effective rate was 92.9% (52/56) was significantly higher in the control group, 73.2% (41/56) (P <0.05); and in patients with no adverse reactions. Conclusion Tongxinluo treatment of angina pectoris efficacy, side effects, safety, should be widely used in clinical.
